Skip to main
AMTX

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Aemetis is poised for success with strong plans for financial growth, including a goal of reaching $1 billion in revenue in 2025 and $2 billion in 2027. The company has demonstrated progress in its key biogas and cellulosic ethanol production projects, and its favorable outlook for 2026 include ramping up its India plant, developing new sustainable fuel projects, and improving its existing operations. Despite its high risks and current losses, Aemetis's current valuation presents a significant opportunity for investors.

Bears say

Aemetis is facing high risks with potential for positive outcomes in the future, such as the possibility of expanding usage for E15 fuel and dairy digestor RNG pathways being approved by CARB. However, there are also potential risks, such as balance sheet/liquidity, political and regulatory risks, and changes in alternative energy financial incentives, that may hinder the company's growth. Despite providing a 5-year financial plan to reach $1 billion in revenue in 2025, the company has continued to face net losses and maintains a highly leveraged balance sheet with a significant amount of debt.

Aemetis (AMTX) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Strong Buy based on their latest research and market trends.

According to 2 analysts, Aemetis (AMTX) has a Strong Buy consensus rating as of May 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.